SEARCH

SEARCH BY CITATION

References

  • 1
    Rajendra S, Kutty K, Karim N. Ethnic differences in the prevalence of endoscopic oesophagitis and Barrett’s oesophagus: the long and short of it all. Dig Dis Sci 2004; 49: 23742.
  • 2
    Kim JY, Kim YS, Jung MK et al. Prevalence of Barrett’s oesophagus in Korea. J Gastroenterol Hepatol 2005; 20: 6336.
  • 3
    Azuma N, Endo T, Arimura Y et al. Prevalence of Barrett’s oesophagus and expression of mucin antigens detected by a panel of monoclonal antibodies in Barrett’s esophagus and esophageal adenocarcinoma in Japan. J Gastroenterol Hepatol 2000; 35: 58392.
  • 4
    Chen X, Zhu LR, Hou XH. The characteristics of Barrett’s oesophagus: an analysis of 4120 cases in China. Dis Esophagus 2009; 22: 34853.
  • 5
    Dhawan PS, Alvares JF, Vora IM et al. Prevalence of short segment of specialized columnar epithelium in distal esophagus: association with gastroesophageal reflux. Indian J Gastroenterol 2001; 20: 1447.
  • 6
    Fernandes ML, Seow A, Chan YH, Ho KY. Opposing trends in incidence of oesophageal squamous cell carcinoma and adenocarcinoma in a multi-ethnic Asian country. Am J Gastroenterol 2006; 101: 14306.
    Direct Link:
  • 7
    Shibata A, Matsuda I, Ajiki W, Sobue J. Trend in incidence of adenocarcinoma of the oesophagus in Japan. Jpn J Clin Oncol 1993; 38: 4648.
  • 8
    Haghdoost AA, Hosseini H, Chamani G et al. Rising incidence of adenocarcinoma of the esophagus in Kerman, Iran. Arch Iran Med 2008; 11: 36470.
  • 9
    Rajendra S, Ho JJ. Gastro-oesophageal reflux disease in British and south-east Asian dyspeptic patients. Aliment Pharmacol Ther 2005; 22: 5801.
  • 10
    Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United Staes. Cancer 1998; 83: 204953.
  • 11
    Powell J, McConkey CC. The rising trend in oesophageal adenocarcinoma and gastric cardia. Eur J Cancer Prev 1992; 1: 2659.
  • 12
    Armstrong RW, Borman B. Trends in incidence rates of adenocarcinoma of the oesophagus and gastric cardia in New Zealand, 1978–1992. Int J Epidemiol 1996; 25: 9417.
  • 13
    Hansson LE, Sparen P, Nyren O. Increasing incidence in both histological types of esophageal carcinomas among men in Sweden. Int J Cancer 1993; 54: 4027.
  • 14
    Bollschweiler E, Wolfgarten E, Gutschow C, Holscher AH. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 2001; 92: 54955.
  • 15
    Holmes RS, Vaughan TL. Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol 2007; 17: 29.
  • 16
    Engel LS, Chow WH, Vaughan TL et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 2003; 95: 140413.
  • 17
    Rajendra S, Alahuddin S. Racial differences in the prevalence of heartburn. Aliment Pharmacol Ther 2004; 19: 3756.
  • 18
    Ho KY, Kang JY, Seow A. Prevalence of gastrointestinal symptoms in a multiracial Asian population, with particular reference to reflux-type symptoms. Am J Gastroenterol 1998; 93: 181622.
  • 19
    Rosaida MS, Goh KL. Gastroesophageal reflux disease, reflux oesophagitis and non-erosive reflux disease in a multiracial Asian population: a prospective, endoscopy based study. Eur J Gastroenterol Hepatol 2004; 16: 495501.
  • 20
    Trudgill NJ, Kapur KC, Riley SA. Familial clustering of reflux symptoms. Am J Gastroenterol 1999; 94: 11728.
    Direct Link:
  • 21
    Romero Y, Cameron AJ, Locke GR et al. Familial aggregation of gastroesophageal reflux in patients with Barrett’s esophagus and esophageal adenocarcinoma. Gastroenterology 1997; 113: 144956.
  • 22
    Chak A, Lee T, Kinnard MF et al. Familial aggregation of Barrett’s oesophagus, oesophageal adenocarcinoma and oesophagogastric junctional adenocarcinoma in Caucasian adults. Gut 2002; 51: 3238.
  • 23
    Cameron AJ, Lagergren J, Henriksson C et al. Gastroesophageal reflux disease in monozygotic and dizygotic twins. Gastroenterology 2001; 122: 559.
  • 24
    Mohammed I, Cherkas LF, Riley SA et al. Genetic influences in gastro-oesophageal reflux disease: a twin study. Gut 2003; 52: 10859.
  • 25
    Rajendra S, Ackroyd R, Murad S et al. HLA determinants of susceptibility to Barrett’s oesophagus in Asians: a preliminary report. Aliment Pharmacol Ther 2005; 21: 137783.
  • 26
    Risch N, Burchard E, Ziv E, Tang H. Categorization of humans in biomedical research: genes, race and disease. Genome Biol 2002; 3: Comment2007.1–Comment2007.12.
  • 27
    Fouad YM, Makhlouf MM, Tawfik HM, el-Amin H, Ghany WA, el-Khayat HR. Barrett’s oesophagus: prevalence and risk factors in patients with chronic GERD in upper Egypt. World J Gastroenterol 2009; 15: 35115.
  • 28
    Nasseri-Moghaddam S, Malekzadeh R, Sotoudeh M et al. Lower oesophagus in dyspeptic Iranian patients: a prospective study. J Gastroenterol Hepatol 2003; 18: 31521.
  • 29
    Toruner M, Soykan I, Enzari A et al. Barrett’s oesophagus: prevalence and its relationship with dyspeptic symptoms. J Gastroenterol Hepatol 2004; 19: 53540.
  • 30
    Ang TL, Fock KM, Ng TM, Teo EK, Chua TS, Tan J. A comparison of the clinical, demographic and psychiatric profiles among patients with erosive and non-erosive reflux disease in a multi-ethnic Asian country. World J Gastroenterol 2005; 11: 355861.
  • 31
    Park JJ, Kim JW, Kim HJ et al. The prevalence of and risk factors for Barrett’s oesophagus in a Korean population. A nationwide multicenter prospective study. J Clin Gastroenterol 2009; 43: 90714.
  • 32
    Wong WM, Lam SK, Hui WM et al. Long term prospective follow-up of endoscopic oesophagitis in southern Chinese – prevalence and spectrum of the disease. Aliment Pharmacol Ther 2002; 16: 203742.
  • 33
    Cameron A. Molecular biology of Barrett’s esophagus. In: Sharma P, Sampliner R, eds. Barrett’s Esophagus and Esophageal Adenocarcinoma. Malden, MA, USA: Blackwell Publishing, 2006; 8291.
  • 34
    Hirota WK, Loughney TM, Lazas DT, Maydonovitch CL, Rholl V, Wong RK. Specialized intestinal metaplasia, dysplasia and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 1999; 116: 27785.
  • 35
    Ford AC, Reynolds PD, Forman D, Cooper B, Moayyedi P. A retrospective case control study to determine the risk of Barrett’s oesophagus according to ethnic origin. Gut 2004; 53(Suppl 1): A26.
  • 36
    Wong WM, Kam CL, Wai MH et al. Pathophysiology of gastroesophageal reflux diseases in Chinese: role of transient lower esophageal sphincter relaxation and oesophageal motor dysfunction. Am J Gastroenterol 2004; 99: 208893.
    Direct Link:
  • 37
    Lam SK, Hasan M, Sircus W et al. Comparison of maximal acid output and gastrin response to meals in Chinese and Scottish normal and duodenal ulcer subjects. Gut 1980; 21: 3248.
  • 38
    Raghunath A, Hungin AP, Wooff D, Childs S. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ 2003; 326: 73743.
  • 39
    O’Connor HJ. Helicobacter pylori and gastro-oesophageal reflux disease – clinical implications and management. Aliment Pharmacol Ther 1999; 13: 11727.
  • 40
    Rajendra S, Ackroyd R, Robertson IK, Ho JJ, Karim N, Kutty MK. Helicobacter pylori, ethnicity and the gastro-oesophageal reflux disease spectrum: a study from the East. Helicobacter 2007; 12: 17783.
  • 41
    Ho KY, Chan YH, Kang JY. Increasing trend of reflux oesophagitis and decreasing trend of **Helicobacter pylori infection in patients from a multiethnic Asian country. Am J Gastroenterol 2005; 100: 19238.
    Direct Link:
  • 42
    Abe Y, Ohara S, Koike T et al. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett’s oesophagus in Japan. Am J Gastroenterol 2004; 99: 121321.
    Direct Link:
  • 43
    Abe Y, Iijima K, Koike T et al. Barrett’s oesophagus is characterised by the absence of Helicobacter pylori infection and high levels of serum pepsinogen I concentration in Japan. J Gastroenterol Hepatol 2009; 24: 12934.
  • 44
    Lai CH, Poon SK, Chen YC et al. Lower prevalence of Helicobacter pylori infection with vacAs1a, cagA-positive and babA2-positive genotype in erosive reflux oesophagitis disease. Helicobacter 2005; 10: 57785.
  • 45
    Wu JCY, Sung JJY, Chan FKL et al. Helicobacter pylori infection is associated with milder gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2000; 14: 42732.
  • 46
    Zhang J, Gong J, Zuo AL, Dan Guo X. Relationship of gastric Helicobacter pylori infection to Barrett’s oesophagus and gastro-oesophageal reflux disease in Chinese. World J Gastroenterol 2004; 10: 6725.
  • 47
    Edstein ZR, Farrow DC, Bronner MP, Rosen SN, Vaughan TL. Central adiposity and risk of Barrett’s oesophagus. Gastroenterology 2007; 133: 40311.
  • 48
    Whiteman DC et al. Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. Gut 2008; 57: 17380.
  • 49
    Banow WJ, Orlando RC. The pathogenesis of heartburn in nonerosive reflux disease: a unifying hypothesis. Gastroenterology 2005; 128: 7718.
  • 50
    Kendall BJ, MacDonald GA, Hayward NK et al. Leptin and the risk of Barrett’s oesophagus. Gut 2008; 57: 44854.
  • 51
    Corley DA, Kubo A, Zhao W. Abdominal obesity, ethnicity and gastroesophageal reflux disease. Gut 2007; 56: 75662.
  • 52
    Yasuhara H, Miyake Y, Toyokawa T et al. Large waist circumference is a risk factor for reflux esophagitis in Japanese Males. Digestion 2010; 81: 1817.
  • 53
    Chung SJ. Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case–control study of 7078 Koreans undergoing health check-ups. Gut 2008; 57: 13605.
  • 54
    National Health Surveillance Survey. Singapore: Epidemiology and Disease Control Division, Ministry of Health 2001.
  • 55
    Tan CE, Ma S, Wai D et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition to the metabolic syndrome to Asians. Diabetes Care 2004; 27: 11826.
  • 56
    Borrie J, Goldwater L. Columnar cell-lined oesophagus: assessment of etiology and treatment. A 22 year experience. J Thorac Cardiovasc Surg 1976; 71: 82534.
  • 57
    Cameron AJ. Barrett’s esophagus: prevalence and size of hiatal hernia. Am J Gastroenterol 1999; 94: 20549.
    Direct Link:
  • 58
    Amano Y, Kinoshita Y. Barrett’s esophagus: perspectives on its diagnosis and management in Asian populations. Gastroenterol Hepatol 2008; 4: 4553.
  • 59
    Dent J, El-Serag HB, Wallander MA et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005; 54: 7107.
  • 60
    Asling B, Jirholt J, Hammond P. Collagen type III alpha I is a gastro-oesophageal reflux disease susceptibility gene and a male risk factor for hiatus hernia. Gut 2009; 58: 10639.
  • 61
    Carre IJ, Johnston BT, Thomas PS et al. Familial hiatal hernia in a large five generation family confirming true autosomal dominant inheritance. Gut 1999; 45: 64952.
  • 62
    Mittal RK, Lange RC, McCallum RW. Identification and mechanism of delayed esophageal acid clearance in subjects with hiatus hernia. Gastroenterology 1987; 92: 1305.
  • 63
    Sloan S, Kahrilas PH. Impairment of esophageal emptying with hiatal hernia. Gastroenterology 1991; 100: 596605.
  • 64
    Reid BJ, Li X, Galipeau P, Vaughan TL. Barrett’s oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat Rev Cancer 2010; 10: 87101.
  • 65
    Kim JH, Rhee PL, Lee JH et al. Prevalence and risk factors of Barrett’s esophagus in Korea. J Gastroenterol Hepatol 2007; 22: 90812.
  • 66
    Ho KY, Lee HJ, Wong WY. Curry promotes significant acid reflux in patients with gastroesophageal reflux disease. J Gastroenterol Hepatol 2001; 16(Suppl): A112.
  • 67
    Kubo A et al. Dietary antioxidants, fruits and vegetables and the risk of Barrett’s oesophagus. Am J Gastroenterol 2005; 103: 161425.
    Direct Link:
  • 68
    Thompson OM, Beresford SA, Kirk EA, Vaughan TL. Vegetables and fruit intakes and risk of Barrett’s oesophagus in men and women. Am J Clin Nutr 2009; 89: 8906.